Xoma reported $449.3M in Market Capitalization this April of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
AbbVie USD 403.83B 5.2B Dec/2025
Agenus USD 107M 16M Dec/2025
Agios Pharmaceuticals USD 1.59B 745M Dec/2025
Ardelyx USD 1.42B 89M Dec/2025
BioMarin Pharmaceutical USD 11.42B 1.02B Dec/2025
Celldex Therapeutics USD 1.81B 87M Dec/2025
Curis USD 3M 10M Apr/2026
Eli Lilly USD 1.02T 293.84B Dec/2025
Emergent BioSolutions USD 125M 51M Dec/2023
Incyte USD 19.39B 2.83B Dec/2025
MacroGenics USD 102M 4M Dec/2025
Novartis USD 292.21B 26.55B Dec/2025
Novartis USD 263.08B 17.01B Dec/2025
Pfizer USD 141.57B 6.48B Dec/2025
Prothena USD 514M 11M Dec/2025
Regeneron Pharmaceuticals USD 81.12B 21.53B Dec/2025